FT
RMD icon

Fiduciary Trust’s ResMed RMD Stock Holding History

Fiduciary Trust’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$568K Sell
2,913
-3,673
-56% -$761K 0.01% 564
2026
Q1 		$1.48M Sell
6,586
-12
-0.2% -$2.99K 0.02% 329
2025
Q4 		$1.59M Sell
6,598
-63
-0.9% -$16.1K 0.02% 328
2025
Q3 		$1.82M Buy
6,661
+34
+0.5% +$9.29K 0.02% 296
2025
Q2 		$1.71M Buy
6,627
+321
+5% +$76.6K 0.02% 301
2025
Q1 		$1.41M Hold
6,306
– – 0.02% 330
2024
Q4 		$1.44M Buy
6,306
+150
+2% +$36.1K 0.02% 299
2024
Q3 		$1.5M Hold
6,156
– – 0.02% 301
2024
Q2 		$1.18M Sell
6,156
-184
-3% -$37.3K 0.02% 312
2024
Q1 		$1.26M Sell
6,340
-607
-9% -$111K 0.02% 309
2023
Q4 		$1.2M Buy
6,947
+4,116
+145% +$632K 0.02% 307
2023
Q3 		$419K Sell
2,831
-46
-2% -$8.32K 0.01% 469
2023
Q2 		$629K Hold
2,877
– – 0.01% 404
2023
Q1 		$630K Hold
2,877
– – 0.01% 399
2022
Q4 		$599K Hold
2,877
– – 0.01% 426
2022
Q3 		$628K Hold
2,877
– – 0.01% 405
2022
Q2 		$603K Sell
2,877
-2
-0.1% -$426 0.01% 418
2022
Q1 		$698K Hold
2,879
– – 0.01% 415
2021
Q4 		$750K Hold
2,879
– – 0.01% 398
2021
Q3 		$759K Sell
2,879
-175
-6% -$47.9K 0.01% 391
2021
Q2 		$753K Hold
3,054
– – 0.01% 384
2021
Q1 		$593K Hold
3,054
– – 0.01% 423
2020
Q4 		$649K Hold
3,054
– – 0.01% 386
2020
Q3 		$524K Buy
3,054
+1,600
+110% +$295K 0.01% 389
2020
Q2 		$279K Hold
1,454
– – 0.01% 470
2020
Q1 		$215K Buy
+1,454
New +$232K 0.01% 459

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fiduciary Trust's RMD Position: Q2 2026 in Review

Fiduciary Trust reduced its ResMed (RMD) stake by 56% in Q2 2026, selling an estimated $761K and leaving 2,913 shares worth $568K. The position accounts for 0.01% of the portfolio, ranked #564.

Fiduciary Trust first reported a position in RMD in Q1 2020 and has held it in 26 quarters since. The position peaked at $1.82M in Q3 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Fiduciary Trust held 2,913 shares of ResMed worth $568K as of Q2 2026.
  • Fiduciary Trust sold 3,673 ResMed shares in Q2 2026, an estimated $761K.
  • ResMed made up 0.01% of Fiduciary Trust's portfolio in Q2 2026, its #564 holding.
  • Fiduciary Trust first reported a position in ResMed in Q1 2020 and has held it in 26 quarters since.
  • Fiduciary Trust's ResMed position peaked at $1.82M in Q3 2025.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.